effective half life - Axtarish в Google
The time required for the activity of a particular radioisotope deposited in a living organism, such as a human or an animal, to be reduced by 50 percent as a result of the combined action of radioactive decay and biological elimination.
Effective half-life Effective half-life
В фармакокинетике эффективный период полувыведения — это скорость накопления или элиминации биохимического или фармакологического вещества в организме; это аналог биологического периода полураспада, когда кинетика регулируется несколькими... Википедия (Английский язык)
In pharmacokinetics, the effective half-life is the rate of accumulation or elimination of a biochemical or pharmacological substance in an organism; it is ...
Effective half-life is the time it takes for the amount of a specific radionuclide in the body to decrease to half of its initial value of radioactive decay ... What is half-life? · The effective half-life of...
The effective half-life (T eff ), which is the result of biological and physical loss, has been commonly used as the unit of the elimination rate.
The effective half-life is the rate of accumulation or elimination of a biochemical or pharmacological substance in an organism; it is the analog of biological ...
Effective Half-Life is defined as the period of time required to reduce the radioactivity level of an internal organ or of the whole body to exactly one half ...
The table indicates the physical, biological and resulting determined effective half-lifeXThe period during which half of the nuclei decay in a quanti... of ...
Effective half-life refers to the amount of time it takes for a certain radioactive substance in your body to decrease by half through natural processes.
Effective half-life = 1.5 X test duration. Ideally, a radiopharmaceutical's effective half-life equals approximately 1.5 times the duration of the diagnostic ...
Novbeti >

Ростовская обл. -  - 
Axtarisha Qayit
Anarim.Az


Anarim.Az

Sayt Rehberliyi ile Elaqe

Saytdan Istifade Qaydalari

Anarim.Az 2004-2023